Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrea I. Loaiza Perez"'
Autor:
Maria Cristina Soraires Santacruz, Aldana Sólimo, Andrea I. Loaiza Perez, Mariana A. Callero, Elisa Bal de Kier Joffé, Liliana M. Finkielsztein
Publikováno v:
Journal of Cellular Physiology. 233:4677-4687
Breast cancer is the first cause of cancer death in women. Many patients are resistant to current therapies, and even those were sensitive at first may eventually become resistant later. Thiosemicarbazones (TSCs) are synthetic compounds that exhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305bf35b5033dab58c186f098fe0406c
https://doi.org/10.1002/jcp.26240
https://doi.org/10.1002/jcp.26240
Autor:
Cristina E. Rodríguez, Elisa Bal de Kier Joffé, Aldana Sólimo, Mariana A. Callero, Andrea I. Loaiza Perez
Publikováno v:
Journal of Cellular Biochemistry. 118:2841-2849
Aminoflavone (AFP 464, NSC 710464), an antitumor agent which recently entered phase II clinical trials, acts against estrogen-positive breast cancer (ER+). AFP 464, which has a unique mechanism of action by activating aryl hydrocarbon receptor (AhR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc3d0edccb2759d0150fb339c421e982
https://doi.org/10.1002/jcb.25934
https://doi.org/10.1002/jcb.25934
Autor:
Aldana, Sólimo, Maria Cristina, Soraires Santacruz, Andrea I, Loaiza Perez, Elisa, Bal de Kier Joffé, Liliana M, Finkielsztein, Mariana A, Callero
Publikováno v:
Journal of cellular physiology. 233(6)
Breast cancer is the first cause of cancer death in women. Many patients are resistant to current therapies, and even those were sensitive at first may eventually become resistant later. Thiosemicarbazones (TSCs) are synthetic compounds that exhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9d49da439eb78c52fbaa76ede071d96
https://pubmed.ncbi.nlm.nih.gov/29111571
https://pubmed.ncbi.nlm.nih.gov/29111571
Autor:
Mariana A, Callero, Cristina E, Rodriguez, Aldana, Sólimo, Elisa, Bal de Kier Joffé, Andrea I, Loaiza Perez
Publikováno v:
Journal of cellular biochemistry. 118(9)
Aminoflavone (AFP 464, NSC 710464), an antitumor agent which recently entered phase II clinical trials, acts against estrogen-positive breast cancer (ER+). AFP 464, which has a unique mechanism of action by activating aryl hydrocarbon receptor (AhR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bfa5e5ad65e73bfa83fe382b7bcc8de2
https://pubmed.ncbi.nlm.nih.gov/28206673
https://pubmed.ncbi.nlm.nih.gov/28206673
Autor:
Mariana A, Callero, Gabriela A, Luzzani, Diana O, De Dios, Tracey D, Bradshaw, Andrea I Loaiza, Perez
Publikováno v:
Journal of cellular biochemistry. 114(10)
2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole (5F203, NSC 703786) lysylamide belongs to a novel mechanistic class of antitumor agents. It elicits activity against ovarian, breast, kidney and colorectal cancer models. In sensitive breast cancer cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a02109a8853fd61c1372acbb577ef54
https://pubmed.ncbi.nlm.nih.gov/23696052
https://pubmed.ncbi.nlm.nih.gov/23696052